Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
March 13 - 17, 2012
The 2012 meeting is intended to bring together a diverse group of scientists studying various molecular, genetic and biochemical approaches to the analysis of the PTEN pathway at the cellular level and in develo pment and diseases including cancer, diabetes, and neurological disorders such as autism. Junior and senior researchers will join to discuss their latest research findings and tech nical approaches toward the analysis of the PTEN pathway. Particular emphasis will be given to model systems, disease pathogenesis and therapy. While a number of speakers have been invited, please note that the majority of oral presentations will be drawn from openly submitted abstracts. Session Themes:
* PTEN Regulation
* Upstream of PTEN
* Downstream of PTEN (PDK 1/mTORC2/AKT)
* Intersecting Pathways: AMPK/TSC/mTORC1
* Therapeutic Modulation of the Pathway
* Aging, Metabolism and Cancer
* Disease Models
|
|
|
Invited Speakers:
|
|
Invited Speakers & Session Chairs:
Domenico Acilli, Columbia University
John Blenis, Harvard Medical School
Saskia Brachmann,Novartis
Anne Brunet, Stanford University
Julian Downward, Cancer Research UK
Britta Eickolt, King’s College London
Jeff Engelman, Harvard Medical School
David Kwiatkowski, Harvard Medical School
Gordon Mills, MD Anderson
Carole Parent, NCI
Alex Toker, Harvard Medical School
Lloyd Trotman, Cold Spring Harbor Laboratory
David Sabatini, MIT
Nahum Sonenberg, McGill University
Peter Vogt, Scripps Research Institute
Roger Williams, MRC, UK
Jean Zhao, Harvard Medical School
|
|